PRF Technologies (PRFX) Intangibles (2025)
PRF Technologies' (PRFX) quarterly Intangibles came in at $7.4 million in Q4 2025, up 4.02% on a QoQ basis from $7.1 million in Q2 2025.
PRF Technologies (PRFX) Intangibles (2025) Analysis & Trends
PRF Technologies (PRFX) has 1 years of Intangibles data on file, last reported at $7.4 million in Q4 2025.
- Quarterly Intangibles changed N/A year-over-year to $7.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.4 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 million, changed N/A from the prior year.
- Intangibles improved to $7.4 million in Q4 2025, from $7.1 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $7.4 million in Q4 2025 to a low of $7.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | 7.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.12 Mn |